Company intelligence / Profile preview

Biomica

Rehovot, Central District / N/A, Israelbiomicamed.com ↗

Ownership: Public · EVGN
Development stage: Phase 1

Overview

Biomica develops innovative microbiome-based therapeutics using its proprietary PRISM platform, focusing on cancer, immune-mediated, and infectious diseases. The company leverages big data and AI to identify functional elements of the human microbiome for targeted therapy development. Recent financing rounds have supported advancement of its pipeline

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Microbiome-based therapeutics (live bacterial consortia)
Industry: Biotech

Drug pipeline

12 assets

BMC128

11 more assets in the full pipeline.

Request access →

Partnerships

Engaged in strategic partnerships via events like the Microbiome Times Partnering Forum; specific partners not named publicly as of latest updates

Financials

Market cap: $4.3M
Total revenue: $347K
Enterprise value: $-2.9M

Beyond the preview

Go deeper on Biomica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomica.

Explore the full profile